NCT00304187View on ClinicalTrials.gov

Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Bulimia NervosaEating Disorders
Interventions
DRUG

Erythromycin

Erythromycin, 250 mg or 500 mg, three times a day for 6 weeks

DRUG

Placebo

Placebo, 250 mg or 500 mg, three times a day for 6 weeks

Trial Locations (1)

10032

Eating Disorders Clinic, New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00304187 - Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa | Biotech Hunter | Biotech Hunter